Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |